Renovaro (RENB) News Today $1.02 +0.20 (+24.55%) (As of 12:03 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Renovaro (NASDAQ:RENB) Trading Up 6.5% - Still a Buy?Renovaro (NASDAQ:RENB) Trading 6.5% Higher - Still a Buy?November 21, 2024 | marketbeat.comRenovaro BioSciences issues shareholder letterNovember 5, 2024 | markets.businessinsider.comRenovaro benoemt nieuwe CEO om kankertechnologie te bevorderenNovember 4, 2024 | nl.investing.comRenovaro Issues Shareholder Letter and Provides Corporate UpdateNovember 4, 2024 | globenewswire.comRenovaro BioSciences files $200M mixed securities shelfOctober 31, 2024 | markets.businessinsider.comRenovaro Names Weinstein as CEO; Four New Board AppointmentsOctober 18, 2024 | marketwatch.comRenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore SequencingOctober 17, 2024 | globenewswire.comRenovaro Inc: Renovaro Announces Strategic Restructuring and Leadership TransitionOctober 17, 2024 | finanznachrichten.deRenovaro Announces Strategic Restructuring and Leadership TransitionOctober 16, 2024 | globenewswire.comRenovaro (NASDAQ:RENB) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comPersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care DiagnosticsSeptember 19, 2024 | markets.businessinsider.comIndependent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer DetectionSeptember 18, 2024 | markets.businessinsider.comRenovaro seeks strategic investors for subsidiary CubeSeptember 13, 2024 | uk.investing.comRenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology CongressSeptember 13, 2024 | globenewswire.comRenovaro Inc: RenovaroCube Announces Strategic Offering of Up to 20% OwnershipSeptember 11, 2024 | finanznachrichten.deRenovaro zoekt strategische investeerders voor dochteronderneming CubeSeptember 11, 2024 | nl.investing.comRenovaro To Seek Funds From Strategic Investors To Acquire Up To 20% Of RenovaroCubeSeptember 11, 2024 | markets.businessinsider.comRenovaroCube Announces Strategic Offering of Up to 20% OwnershipSeptember 11, 2024 | globenewswire.comRENB Sep 2024 2.000 call (RENB240920C00002000)August 17, 2024 | finance.yahoo.comVanguard Group Inc. Grows Stock Holdings in Renovaro Inc. (NASDAQ:RENB)Vanguard Group Inc. lifted its position in Renovaro Inc. (NASDAQ:RENB - Free Report) by 904.0% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,916,672 shares of the company's stock after buying an additionaAugust 15, 2024 | marketbeat.comRenovaro Inc RENBJuly 25, 2024 | morningstar.comInsider Selling: Renovaro Inc. (NASDAQ:RENB) Major Shareholder Sells 16,362 Shares of StockJuly 20, 2024 | insidertrades.comRenovaro Inc. (NASDAQ:RENB) Major Shareholder Sells $23,888.52 in StockRenovaro Inc. (NASDAQ:RENB - Get Free Report) major shareholder Anderson Wittekind William sold 16,362 shares of Renovaro stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $1.46, for a total value of $23,888.52. Following the completion of the transaction, the insider now owns 841,433 shares in the company, valued at $1,228,492.18. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Large shareholders that own at least 10% of a company's stock are required to disclose their transactions with the SEC.July 19, 2024 | marketbeat.comAnderson Wittekind William Sells 21,954 Shares of Renovaro Inc. (NASDAQ:RENB) StockJuly 18, 2024 | insidertrades.comRenovaro Inc. (NASDAQ:RENB) Major Shareholder Sells $30,955.14 in StockRenovaro Inc. (NASDAQ:RENB - Get Free Report) major shareholder Anderson Wittekind William sold 21,954 shares of the stock in a transaction on Monday, July 15th. The stock was sold at an average price of $1.41, for a total value of $30,955.14. Following the transaction, the insider now directly owns 875,795 shares in the company, valued at approximately $1,234,870.95. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Major shareholders that own at least 10% of a company's shares are required to disclose their transactions with the SEC.July 17, 2024 | marketbeat.comAnderson Wittekind William Sells 14,896 Shares of Renovaro Inc. (NASDAQ:RENB) StockJuly 16, 2024 | insidertrades.comRenovaro Inc. (NASDAQ:RENB) Sees Large Increase in Short InterestRenovaro Inc. (NASDAQ:RENB - Get Free Report) saw a large growth in short interest in June. As of June 30th, there was short interest totalling 2,560,000 shares, a growth of 62.0% from the June 15th total of 1,580,000 shares. Approximately 3.2% of the company's shares are sold short. Based on an average daily trading volume, of 781,900 shares, the days-to-cover ratio is currently 3.3 days.July 12, 2024 | marketbeat.comRenovaro Inc. (NASDAQ:RENB) Major Shareholder Sells $75,500.00 in StockJuly 9, 2024 | insidertrades.comRenovaro Inc. (NASDAQ:RENB) Major Shareholder Sells $22,006.50 in StockJune 28, 2024 | insidertrades.comRenovaro Inc. (NASDAQ:RENB) Major Shareholder Sells $79,000.00 in StockJune 19, 2024 | insidertrades.comRenovaro Inc. (NASDAQ:RENB) Sees Significant Decrease in Short InterestRenovaro Inc. (NASDAQ:RENB - Get Free Report) was the recipient of a significant decrease in short interest in May. As of May 31st, there was short interest totalling 1,460,000 shares, a decrease of 24.4% from the May 15th total of 1,930,000 shares. Based on an average daily volume of 599,600 shares, the short-interest ratio is currently 2.4 days. Currently, 1.4% of the company's shares are sold short.June 14, 2024 | marketbeat.comRenovaro, Inc. Announces $10 million in Equity CommittedJune 14, 2024 | globenewswire.comRenovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer ImmunotherapyMay 24, 2024 | globenewswire.comBiotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032May 24, 2024 | tmcnet.comRenovaro Inc. (RENB)May 16, 2024 | finance.yahoo.comRENB Stock Earnings: Renovaro Biosciences Reported Results for Q3 2024May 16, 2024 | investorplace.comRenovaro: Fiscal Q3 Earnings SnapshotMay 15, 2024 | washingtonpost.comTransforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on FragmentomicsApril 30, 2024 | globenewswire.comRenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics PartnershipApril 24, 2024 | globenewswire.comRenovaro appoints distinguished professor as new Chair of Scientific BoardApril 20, 2024 | uk.investing.comRenovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient CareApril 18, 2024 | finance.yahoo.comRenovaro Inc. (NASDAQ:RENB) Sees Large Decline in Short InterestRenovaro Inc. (NASDAQ:RENB - Get Free Report) was the target of a large decline in short interest in February. As of February 29th, there was short interest totalling 825,900 shares, a decline of 24.9% from the February 14th total of 1,100,000 shares. Based on an average daily volume of 195,900 shares, the short-interest ratio is currently 4.2 days. Currently, 1.5% of the company's stock are short sold.March 15, 2024 | marketbeat.comONGOING INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RenovaroMarch 12, 2024 | markets.businessinsider.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENBMarch 11, 2024 | prnewswire.comINVESTOR REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RenovaroMarch 10, 2024 | markets.businessinsider.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENBMarch 3, 2024 | prnewswire.comRenovaro Shareholder NoticeFebruary 28, 2024 | stockhouse.comRenovaro Shareholder AlertFebruary 26, 2024 | stockhouse.comROSEN, LEADING INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENBFebruary 25, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENBFebruary 24, 2024 | prnewswire.com Get Renovaro News Delivered to You Automatically Sign up to receive the latest news and ratings for RENB and its competitors with MarketBeat's FREE daily newsletter. Email Address 3 Dirt-Cheap Stocks You Can’t Afford to Ignore (Ad)Often, investors will overlook stocks just because they're cheap. It's a common thought that a cheap price tag means that something must be wrong with the company. But this couldn't be further from the case in many instances. Get your FREE look at these THREE companies right here. RENB Media Mentions By Week RENB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RENB News Sentiment▼1.890.87▲Average Medical News Sentiment RENB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RENB Articles This Week▼11▲RENB Articles Average Week Get Renovaro News Delivered to You Automatically Sign up to receive the latest news and ratings for RENB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Pharming Group News Y-mAbs Therapeutics News PureTech Health News Emergent BioSolutions News Terns Pharmaceuticals News Zevra Therapeutics News Organogenesis News SIGA Technologies News Arcturus Therapeutics News Xeris Biopharma News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RENB) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Renovaro Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Renovaro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
